These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4402039)

  • 1. Reduction of histamine in mouse brain by N 1 -(DL-seryl)-N 2 -(2,3,4-trihydroxybenzyl) hydrazine and reserpine.
    Atack C
    J Pharm Pharmacol; 1971 Dec; 23(12):992-3. PubMed ID: 4402039
    [No Abstract]   [Full Text] [Related]  

  • 2. The acute effects of reserpine and NSD-1015 on the brain serotonin synthesis rate measured by an autoradiographic method.
    Mück-Seler D; Diksic M
    Neuropsychopharmacology; 1995 May; 12(3):251-62. PubMed ID: 7612159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopa-induced locomotor stimulation after inhibition of extracerebral decarboxylase.
    Bartholini G; Blum JE; Pletscher A
    J Pharm Pharmacol; 1969 May; 21(5):297-301. PubMed ID: 4390121
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of reserpine on histamine metabolism in the mouse brain.
    Muroi N; Oishi R; Saeki K
    J Pharmacol Exp Ther; 1991 Mar; 256(3):967-72. PubMed ID: 2005590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavior and biochemical effects of preferentially protecting monoamines in the brain against the action of reserpine.
    Butcher LL; Rhodes DL; Yuwiler A
    Eur J Pharmacol; 1972 May; 18(2):204-12. PubMed ID: 4537669
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction of N-(DL-seryl)N'-(2,3,4-trihydroxybenzyl)-hydrazine with L-dopa decarboxylase from pig kidney.
    Borri-Voltattorni C; Minelli A; Borri P
    Experientia; 1977 Feb; 33(2):158-60. PubMed ID: 300332
    [No Abstract]   [Full Text] [Related]  

  • 7. Metatyrosine-induced reversal of the suppression of the conditioned avoidance response in reserpine-treated rats.
    Engel J
    Acta Pharmacol Toxicol (Copenh); 1971; 30(3):278-88. PubMed ID: 4945487
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of histidine-decarboxylase inhibitors on gastric acid secretion in the rat.
    Castellucci A; Megazzini P
    Arzneimittelforschung; 1976; 26(1):62-5. PubMed ID: 947180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of drugs on the temperature-lowering effect of harmaline.
    Bruinvels J; Sourkes TL
    Eur J Pharmacol; 1968 Aug; 4(1):31-9. PubMed ID: 5692910
    [No Abstract]   [Full Text] [Related]  

  • 10. Accumulation of 5-hydroxytryptophan in mouse brain after decarboxylase inhibition.
    Carlsson A; Lindqvist M
    J Pharm Pharmacol; 1970 Sep; 22(9):726-7. PubMed ID: 4394774
    [No Abstract]   [Full Text] [Related]  

  • 11. Nonmast-cell histamine kinetics. IV. Interrelationships between synthesis, binding and catabolism of 3 H-histamine in vivo.
    Johnson HL
    J Pharmacol Exp Ther; 1971 Jun; 177(3):579-90. PubMed ID: 5568812
    [No Abstract]   [Full Text] [Related]  

  • 12. Restoration of locomotor activity in mice by low L-DOPA doses after suppression by alpha-methyltyrosine but not by reserpine.
    Ahlenius S; Andén NE; Engel J
    Brain Res; 1973 Nov; 62(1):189-99. PubMed ID: 4358099
    [No Abstract]   [Full Text] [Related]  

  • 13. Stimulation of brain dopamine autoreceptors by remoxipride administration in reserpine-treated male rats.
    Ahlenius S; Ericson E; Wijkström A
    J Pharm Pharmacol; 1993 Mar; 45(3):237-9. PubMed ID: 8097786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of tissue histamine formation by decaborane.
    Medina MA; Landez JH; Foster LL
    J Pharmacol Exp Ther; 1969 Sep; 169(1):132-7. PubMed ID: 5804607
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation between brain dopamine levels and 1-dopa activity in anti-Parkinson tests.
    Horst WD; Pool WR; Spiegel HE
    Eur J Pharmacol; 1973 Mar; 21(3):337-42. PubMed ID: 4736076
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the mode of action of alpha-methyldopa.
    Henning M
    Acta Physiol Scand Suppl; 1969; 322():1-37. PubMed ID: 4311985
    [No Abstract]   [Full Text] [Related]  

  • 17. Dynamics of the regulation of histamine levels in mouse brain.
    Taylor KM; Snyder SH
    J Neurochem; 1972 Feb; 19(2):341-54. PubMed ID: 5010081
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of L-dopa and an inhibitor of peripheral decarboxylation on glucose metabolism in brain.
    Tyce GM
    J Neurochem; 1976 Dec; 27(6):1397-403. PubMed ID: 1003214
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of dopadecarboxylase in the rat by a series of benzyloxyamines.
    Lazare R; Watson PA
    J Pharm Pharmacol; 1972 May; 24(5):361-6. PubMed ID: 4403804
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism of release of alpha-methylated noradrenaline analogues by monoamine oxidase inhibitors.
    Carlsson A; Lindqvist M; Waldeck B
    Eur J Pharmacol; 1968 Apr; 3(1):34-9. PubMed ID: 5654667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.